ResMed reported $1.33B in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Ansell ANN:AU $ 1.37B 23.75M
Cochlear COH:AU $ 827.6M 6.9M
CSL CSL:AU $ 6.55B 1.77B
Estia Health EHE:AU $ 329.45M 12.17M
Fisher & Paykel Healthcare FPH:AU 724.64M 175.36M
Healius Ltd HLS:AU $ 998.2M 339.8M
Integral Diagnostics Ltd IDX:AU 179.4M 2.13M
Japara Healthcare JHC:AU 206.85M 5.83M
Mayne Pharma MYX:AU $ 228.46M 31.65M
Nanosonics Ltd NAN:AU $ 59.67M 972K
Opthea Ltd OPT:AU 125.65K 371.33K
Polynovo Ltd PNV:AU 23.34M 5.24M
Ramsay Health Care RHC:AU $ 6.74B 270.4M
Regis Healthcare REG:AU 392.19M 3.41M
ResMed RMD:AU $ 1.33B 461.02M
Sigma Healthcare Ltd SIG:AU 1.89B 120.54M
Sonic Healthcare SHL:AU $ 4.58B 172.9M
Telix Pharmaceuticals Ltd TLX:AU 24.05M 19.36M